IL165088A0 - Transgenic ungulates capable of human antibody production - Google Patents

Transgenic ungulates capable of human antibody production

Info

Publication number
IL165088A0
IL165088A0 IL16508803A IL16508803A IL165088A0 IL 165088 A0 IL165088 A0 IL 165088A0 IL 16508803 A IL16508803 A IL 16508803A IL 16508803 A IL16508803 A IL 16508803A IL 165088 A0 IL165088 A0 IL 165088A0
Authority
IL
Israel
Prior art keywords
antibodies
human antibody
antibody production
transgenic ungulates
inactivation
Prior art date
Application number
IL16508803A
Other languages
English (en)
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of IL165088A0 publication Critical patent/IL165088A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8773—Ovine embryos
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16508803A 2002-05-17 2003-05-19 Transgenic ungulates capable of human antibody production IL165088A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38153102P 2002-05-17 2002-05-17
US42505602P 2002-11-08 2002-11-08
PCT/US2003/015937 WO2003097812A2 (fr) 2002-05-17 2003-05-19 Ongules transgeniques capables de produire des anticorps humains

Publications (1)

Publication Number Publication Date
IL165088A0 true IL165088A0 (en) 2005-12-18

Family

ID=29553536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16508803A IL165088A0 (en) 2002-05-17 2003-05-19 Transgenic ungulates capable of human antibody production

Country Status (10)

Country Link
EP (1) EP1513397B1 (fr)
JP (1) JP2005525817A (fr)
KR (1) KR20050000558A (fr)
CN (1) CN1668187A (fr)
AT (1) ATE464389T1 (fr)
CA (1) CA2484655A1 (fr)
DE (1) DE60332111D1 (fr)
IL (1) IL165088A0 (fr)
NZ (1) NZ536341A (fr)
WO (1) WO2003097812A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110029D0 (en) 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
US7420099B2 (en) * 2004-04-22 2008-09-02 Kirin Holdings Kabushiki Kaisha Transgenic animals and uses thereof
US8785187B2 (en) * 2004-06-09 2014-07-22 The University Court Of The University Of Edinburgh Neural stem cells
AU2005299413A1 (en) * 2004-10-22 2006-05-04 Revivicor, Inc. Ungulates with genetically modified immune systems
TW200817512A (en) 2006-07-07 2008-04-16 Kirin Pharma Kk Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector
DK2348827T3 (en) 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS
EP3187581A1 (fr) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Populations cibles de cellules précurseurs d'oligodendrocytes et leurs procédés de fabrication et d'utilisation
PL2498801T3 (pl) 2009-11-13 2018-08-31 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
EP2502993B1 (fr) 2009-11-17 2017-07-26 Sanford Applied Biosciences L.L.C. Vecteur de chromosome humain artificiel
CN104755493B (zh) * 2012-08-03 2020-12-25 Sab有限责任公司 用于在转基因动物中生产人类抗体的复杂的染色体工程
CA2900915A1 (fr) * 2013-02-13 2014-08-21 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Cetuximab avec glycosylation modifiee et utilisations associees
CA2909139C (fr) * 2013-04-18 2021-07-06 Institut National De La Sante Et De La Recherche Medicale Composition ayant une immunogenicite reduite
CN107001449A (zh) * 2014-10-15 2017-08-01 芝诺锡拉公司 具有降低的免疫原性的组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
DK0546073T3 (da) * 1990-08-29 1998-02-02 Genpharm Int Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
CA2230759C (fr) * 1995-08-29 2012-02-21 Kirin Beer Kabushiki Kaisha Animal chimerique et procede pour le produire
ATE387495T1 (de) 1996-12-03 2008-03-15 Amgen Fremont Inc Vollkommen humane antikörper die egfr binden
WO2001035735A1 (fr) * 1999-11-19 2001-05-25 Hematech, Llc Production d'ongules, de preference des bovins, qui produisent des immunoglobulines humaines
KR100882030B1 (ko) * 2000-11-17 2009-02-09 교와 핫꼬 기린 가부시키가이샤 클로닝된 트랜스제닉 유제류에서 이종 (사람)면역글로블린의 발현
US20020108132A1 (en) * 2001-02-02 2002-08-08 Avigenics Inc. Production of a monoclonal antibody by a transgenic chicken

Also Published As

Publication number Publication date
EP1513397B1 (fr) 2010-04-14
AU2003245300A1 (en) 2003-12-02
CN1668187A (zh) 2005-09-14
WO2003097812A2 (fr) 2003-11-27
ATE464389T1 (de) 2010-04-15
EP1513397A2 (fr) 2005-03-16
CA2484655A1 (fr) 2003-11-27
NZ536341A (en) 2008-05-30
WO2003097812A3 (fr) 2004-02-12
EP1513397A4 (fr) 2007-10-24
JP2005525817A (ja) 2005-09-02
DE60332111D1 (de) 2010-05-27
KR20050000558A (ko) 2005-01-05

Similar Documents

Publication Publication Date Title
DE60144305D1 (de) Expression von xenogenen (humanen) Immunglobulinen in klonierten, transgenen Huftieren
CY1123535T1 (el) Υποκαταστατο θεραπευτικο τελικο σημειο για βασιζομενη σε anti-ctla-4 ανοσοθεραπεια ασθενειας
NO2022001I1 (no) Pazopanib
EP1354034B8 (fr) Rongeurs transgeniques et transchromosomiques pour la fabrication d&#39;anticorps humains
IL165088A0 (en) Transgenic ungulates capable of human antibody production
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
CY1110759T1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
ATE423571T1 (de) Verwendung von bispezifischen antikörpern gegen einen aktivierenden rezeptor fcepsilonri und gegen einen inhibierenden rezeptor ox2ra (cd200ra) zur regulierung der immunantworten
NI200200128A (es) &#34;anticuerpos para cd40&#34;
IL244803B (en) Human anti-beta antibodies and their use
ATE444308T1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
ATE390480T1 (de) Transplant-akzeptanz induzierende zellen monocytären ursprungs, sowie deren herstellung und verwendung
PH12014501872A1 (en) P-cadherin antibodies
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
DE502005011119D1 (fr)
BRPI0314814C1 (pt) anticorpo compreendendo uma variante de fc
NO20045645L (no) Noytraliserende humant anti-IGFR-antistoff
ATE395082T1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
HK1154904A1 (zh) 天然 抗體及其抑制劑
WO2005049652A3 (fr) Procede de generation in vitro d&#39;une diversite d&#39;anticorps
EA200501137A1 (ru) Способ и промежуточные соединения для получения оланзапина
WO2005047456A3 (fr) Anticorps anti-idiotypiques de l&#39;anticorps monoclonal humain sc-1, leur fabrication et leur utilisation